Home > Drug Search >
  • company_query: BioGeneric
  •   > 
Drug Filter
Category:
chemistry (5) biology (28)
Status:
Approved (2) NDA Filing (1) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (9) Phase Ⅰ (17)
Clinical Stage:
Active (27) Discontinued (4)
Bio-Type:
Coagulation factor (1) Gene therapy (1) CAR T cell therapy (11) Vaccine (6) Blood extraction (1) Microbial extract (1) Recombinant cytokines (1) Whole antibody (2) ADC (1) Fusion protein (1)
Indication:
Acne (1) Acute lymphoblastic leukaemia (ALL) (3) Atopic dermatitis (1) Chronic lymphocytic leukemia (CLL) (3) Cutaneous T cell lymphoma (CTCL) (1) Gastrointestinal stromal tumors (GISTs) (1) Glioblastoma multiforme (1) HBV infection (2) HCV infection (1) Hepatocellular carcinoma (HCC) (2) Facial-wrinkles (1) Leukemia (1) Lymphoma (2) Malignancies (1) Melanoma (1) Multiple myeloma (MM) (1) Non-Hodgkin’s lymphoma (NHL) (5) Psoriasis (1) Rheumatoid arthritis (RA) (2) Norovirus infections (1) Solid tumours (2) Systemic lupus erythematosus (2) Hodgkin lymphoma (2) Primary humoral immunodeficiency (1) Anthrax (1) Neuroblastoma (2) Biliary cancer (1) Sarcoma (2) Hemophilia B (1) Hyperhidrosis (2) Bleeding (1) Hearing loss (1) Respiratory syncytial virus infection (1) Immunodeficiency disorders (1) Immune thrombocytopenic purpura (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top